62615-26-3

Basic information

• Product Name: Ethanone, 1-(2,4-dihydroxy-3-methoxyphenyl)-
• Synonyms: 2,4-Dihydroxy-3-methoxyacetophenon;2,4-dihydroxy-3-methoxyacetophenone
• CAS NO: 62615-26-3
• Molecular Formula: C9H10O4
• Molecular Weight: 182.176
• Mol File: 62615-26-3.mol
• Article Data: 2

Chemical Properties

• Melting Point: 141–144°C
• CAS DataBase Reference: Ethanone, 1-(2,4-dihydroxy-3-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(2,4-dihydroxy-3-methoxyphenyl)-(62615-26-3)
• EPA Substance Registry System: Ethanone, 1-(2,4-dihydroxy-3-methoxyphenyl)-(62615-26-3)

Safety Data

• Hazardous Substances Data: 62615-26-3(Hazardous Substances Data)

Usage

Preparation

Preparation by catalytic hydrogenolysis of 4-(benzyloxy)-2-hydroxy-3-methoxyacetophenone in the presence of 5% Pd/C in ethyl acetate (90%).

Upstream product

• 29267-67-2 2-methoxyresorcinol 
• 373-61-5 boron trifluoride diacetate 
• 87-66-1 2-hydroxyresorcinol 
• 74-88-4 methyl iodide 
• 64-19-7 acetic acid 
• 75-05-8 acetonitrile 
• 860741-89-5 1-(2,4-diacetoxy-3-methoxy-phenyl)-ethanone 
• 13909-73-4 2',3',4'-trimethoxyacetophenone 

Downstream Products

• 69616-59-7 4-Ethoxy-2-hydroxy-3-methoxyacetophenon 
• 29267-67-2 2-methoxyresorcinol 
• 69616-60-0 4-Ethoxy-2,3,5-trimethoxyacetophenon 
• 144632-79-1 2',4',4-tribenzyloxy-3'-methoxychalcone 
• 124704-82-1 1-(2',4'-dihydroxy-3'-methoxyphenyl)-3-(4''-methoxyphenyl)-2-propene-1-one 
• 144632-78-0 2',4'-dibenzyloxy-3',4-dimethoxychalcone 
• 5396-18-9 2'-hydroxy-3',4'-dimethoxyacetophenone 
• 144632-77-9 2,4-dibenzyloxy-3-methoxyacetophenone 

Relevant articles and documents

CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS

The present invention relates to chromen-4-one derivatives comprising a quaternary group, and to associated multi-salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treatment and prevention of medical disorders and diseases, most especially by modulation of neurotrophic factors (such as BDNF) pathways and modulation of mitochondrial function Formula (I).